Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.51) by 7.84 percent. This is a 14.63 percent decrease over losses of $(0.41) per share from the same period last year.
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.51) by 7.84 percent. This is a 14.63 percent decrease over losses of $(0.41) per share from the same period last year.
Comments